Immobilized enzymes to convert N-sulfo, N-acetyl heparosan to a critical intermediate in the production of bioengineered heparin
- 5 July 2013
- journal article
- Published by Elsevier in Journal of Biotechnology
- Vol. 167 (3), 241-247
- https://doi.org/10.1016/j.jbiotec.2013.06.018
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Uncovering Biphasic Catalytic Mode of C5-epimerase in Heparan Sulfate BiosynthesisJournal of Biological Chemistry, 2012
- Dissecting the substrate recognition of 3- O -sulfotransferase for the biosynthesis of anticoagulant heparinProceedings of the National Academy of Sciences, 2012
- Synthetic heparinCurrent Opinion in Pharmacology, 2012
- Structural characterization of heparins from different commercial sourcesAnalytical and Bioanalytical Chemistry, 2011
- Control of the heparosan N-deacetylation leads to an improved bioengineered heparinApplied Microbiology and Biotechnology, 2011
- Expression of heparan sulfate sulfotransferases in Kluyveromyces lactis and preparation of 3'-phosphoadenosine-5'-phosphosulfateGlycobiology, 2011
- E. coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursorBiotechnology & Bioengineering, 2010
- Lessons learned from the contamination of heparinNatural Product Reports, 2009
- Solution Structures of Chemoenzymatically Synthesized Heparin and Its PrecursorsJournal of the American Chemical Society, 2008
- Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical eventsNature Biotechnology, 2008